Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
Clinical trial NCT05668962 · RECRUITING
Trial details
- NCT number
- NCT05668962
- Sponsor
- Massachusetts General Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2025-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.